Ratiopharm is a German

pharmaceutical company The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients (or self-administered), with the aim to cure them, vaccinate them, or alleviate sympto ...

that is Europe's leading generics brand. Ratiopharm was owned by

Adolf Merckle Adolf Merckle (18 March 1934 – 5 January 2009) was a German entrepreneur and billionaire. He committed suicide at age 74 due to losses during the financial crisis of 2007–2008. He was at one point the fifth-richest person in Germany ...

and makes generic pharmaceuticals. They are based in Ulm, Germany, with products being distributed in over 35 countries worldwide. On 18 March 2010 Teva announced that it planned to acquire Ratiopharm for

US$ The United States dollar (symbol: $; code: USD; also abbreviated US$ or U.S. Dollar, to distinguish it from other dollar-denominated currencies; referred to as the dollar, U.S. dollar, American dollar, or colloquially buck) is the official ...

5 billion. On 10 August 2010 Teva announced that it had completed its acquisition of Ratiopharm. Since June 2017, the company has been managed by Christoph Stoller, General Manager of Teva Germany and Austria (European headquarters). He succeeded Markus Leyck Dieken, who was General Manager from October 2013 and joined the Teva Group Management in June 2017. Previously, Sven Dethlefs, who oversaw the takeover of Ratiopharm by Teva in 2010, held the position for five years until he moved to the group management in Israel in 2013.

References

External links

* Pharmaceutical companies of Germany Companies based in Ulm Pharmaceutical companies established in 1974 Medical and health organisations based in Baden-Württemberg {{Germany-company-stub

See also

References

External links